ANTINEOPLASTIC AGENTS
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
47 ingredients · 364 matching product records. Ontario extract: 2026-08-26.
| Ingredient / brands | Strengths and forms | Ontario listings | Browse |
|---|---|---|---|
| PROCARBAZINE HCLMatulane | 50mg Cap | General benefit | View 1 product |
| RITUXIMABRuxience, Riximyo, Truxima | 10mg/mL Inj Sol (Preservative-Free); 100mg/10mL Inj Sol-10mL Vial Pk; 500mg/50mL Inj Sol-50mL Vial Pk | Limited Use, codes 583, 584, 585, 586; Limited Use, codes 581, 582, 616, 617; Limited Use, codes 575, 576, 587, 588Varies by product. Open the list to check. | View 4 products |
| TAMOXIFEN CITRATEApo-Tamox, Teva-Tamoxifen, Tamofen and 2 more brands | 10mg Tab; 20mg Tab | General benefit; Listed, not a benefitVaries by product. Open the list to check. | View 8 products |
| TEMOZOLOMIDETemodal, Teva-Temozolomide, Taro-Temozolomide and 1 more brand | 5mg Cap; 20mg Cap; 100mg Cap; 140mg Cap 1 more form in product list | General benefit | View 20 products |
| THIOGUANINELanvis | 40mg Tab | General benefit | View 1 product |
| TRIPTORELIN PAMOATETrelstar (1 Month), Trelstar LA (3 Month), Trelstar | 3.75mg/Vial Inj Pd with Sterile Water-Vial Pk; 11.25mg/Vial Inj Pd with Sterile Water-Vial Pk; 3.75mg/Vial Inj Pd-Vial Pk; 11.25mg/Vial Inj Pd-Vial Pk 1 more form in product list | General benefit | View 5 products |
| VINCRISTINE SULFATEOncovin, Vincristine Sulfate | 1mg/mL Inj Sol | Listed, not a benefit; General benefitVaries by product. Open the list to check. | View 2 products |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
10:00 ANTINEOPLASTIC AGENTS.